Diadema Partners’s Zymeworks ZYME Stock Holding History

Diadema Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-240,600	Closed	-$6.33M	–	213
2025 Q4	$6.33M	Buy	240,600 +44,100	+22%	+$962K	1.09%	28
2025 Q3	$3.36M	Buy	196,500 +17,200	+10%	+$246K	0.86%	42
2025 Q2	$2.25M	Hold	179,300	–	–	0.69%	39
2025 Q1	$2.14M	Buy	+179,300	New	+$2.45M	0.56%	43

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Diadema Partners's ZYME Position: Q1 2026 in Review

Diadema Partners opened a new position in Zymeworks (ZYME) in Q1 2026: 142,132 shares worth $3.56M. The stake represents 0.61% of the portfolio and ranks #44 among its holdings.

211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

Diadema Partners held 142,132 shares of Zymeworks worth $3.56M as of Q1 2026.
Zymeworks was a new Diadema Partners position in Q1 2026.
Zymeworks made up 0.61% of Diadema Partners's portfolio in Q1 2026, its #44 holding.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.